An Unusual Case of Proliferative Sickle Cell
Total Page:16
File Type:pdf, Size:1020Kb
AN UNUSUAL CASE OF PROLIFERATIVE SICKLE CELL RETINOPATHY Case Report By : *C Tembo, D Kasongole 1Department of Surgery, School of Medicine, University of Zambia, Lusaka-Zambia 2University Teaching Hospitals - Eye Hospital, Lusaka-Zambia *E-mail Addresses: Chimozi Tembo: [email protected] Citation Style For This Article: Tembo C, Kasongole D. An Unusual Case of Proliferative Sickle Cell Retinopathy. Health Press Zambia Bull. 2019; 3(12); pp 6-8. ABSTRACT Teaching Hospital, Lusaka-Zambia involv- was advised that he needed surgery but Sickle cell haemoglobinopathies are a ing 94 patients, looking at the ocular man- was lost to follow-up. group of inherited disorders character- ifestations of sickle cell disease, found The patient had no history of hyperten- ized by quantitative or qualitative malfor- that ocular abnormalities were high with sion, diabetes mellitus, sickle cell disease, mations of haemoglobin (Hb). Diagnosis 69% of patients showing signs of ocular TB or retroviral disease. Family history of SCD is mainly by haemoglobin elec- manifestations. However, most were not was non-revealing. There was no history trophoresis. Ocular manifestations are causing visual impairment, with only 1% of alcohol intake or smoking. wide, encompassing anterior segment, of the patients being blind as a result of On examination, the general condition non-proliferative and proliferative reti- SCD [3]. was good. There was no pallor, jaundice or nopathy. Proliferative sickle cell retinop- Though PSCR can occur in patients with cyanosis. Visual acuity was hand motion athy (PSCR) represents a very serious sickle cell trait, it is very rare and in most (HM) and 6/18 not improving with pin- complication and may result in blindness cases there are other co-existing systemic hole in the right and left eye, respectively. if not diagnosed and treated early. PSCR disease such as diabetes or an inflamma- Intraocular pressure measured with Gold- rarely occurs in patients with sickle cell tory disorder or history of trauma. PSCR mann applanation was 20 mmHg in the trait, most times in association with an can be classified into five stages [4]. right eye and 18 mmHg in the LE. Slit lamp underlying systemic condition or ocular examination of the anterior segment ex- trauma. We present an unusual case of a Table 1: Proliferative Retinopathy amination was normal in both eyes. healthy young male with no history of sys- temic illness who presented with prolifer- ative sickle cell retinopathy in both eyes. INTRODUCTION Sickle cell trait is thought of as a benign condition in comparison to Sickle cell disease (SCD). Sickling haemoglobinopa- thies are caused by one or more abnormal haemoglobins that induce red blood cells to adopt an anomalous shape under con- ditions of physiological stress such as hy- poxia and acidosis, with resultant vascular occlusion [1]. This results in distal tissue We present an unusual case of prolifera- Fundoscopy of the RE revealed pink disc ischemia and a host of related systemic tive sickle cell retinopathy in a young male with a CDR of 0.4. The blood vessels were and ocular complications. patient who presented with blurred vision sclerosed infero-temporally and the mac- SCD is most common among black Afri- in the left eye for 2 weeks who denied any ula showed a thick epiretinal membrane cans, due to its protective effect against history of sickle cell disease. (ERM) with retinal folds and old vitreous malaria. It also is found, with much less haemorrhage (VH). Fundoscopy of the LE frequency, in eastern Mediterranean and CASE SCENARIO revealed Pink disc with a CDR 0.4. Vessels Middle East populations. A 41-year-old male patient presented were Normal. There was subhyaloid hae- Ocular manifestations of SCD are wide. to UTHs - Eye Hospital complaining of morrhage (SHH) and Salmon patch was Ocular manifestations can be noted in the blurred vision in the Left Eye (LE) for 2 noted supero-temporally. anterior segment and in the posterior seg- weeks. He denied any history of trauma or At this point, an impression pf prolifera- ment in the form of nonproliferative and straining. tive sickle cell retinopathy both eyes with proliferative retinopathy [1]. There is an Past Ocular History revealed that he had epiretinal membrane right eye was made. inverse relationship between the severity been seen on two months earlier com- of systemic disease and the severity of plaining of loss of vision in the Right Eye The Full Blood Count (FBC)/ Differential retinopathy in homozygous SS individuals (RE) for 3 days of spontaneous onset and Count showed thrombocytopaenia while compared to compound heterozygous SC was diagnosed with vitreous haemor- all other parameters were normal. Urea/ subjects [2]. rhage of the RE. He had received intravit- Creatinine/LFTs were normal. Fasting An unpublished study in at the University real Bevacizumab (Avastin) in the RE and blood sugar was within normal limits and 6 so was the chest x-ray. Peripheral Blood Consultation was made to the haematol- Later he developed Hyphaema in the Smear showed red cell morphology of ogist in view of the thrombocytopaenia same eye with raised intraocular pressure. normocytic, normochromic. The white and blood film picture. Patient was coun- Anterior chamber washout was done. cell morphology was mild leukopenia and selled on the guarded visual prognosis. Current status, the RE is blind post en- no blasts were seen. On platelet morphol- Pan-retinal laser photocoagulation (PRP) dophthalmitis with neovascular glaucoma ogy, thrombocytopenia was noted on film. was done for both eyes in two (2) sittings, (NVG) while LE has resolving vitreous The sickling solubility test revealed Het- covering the superior and inferior retina. haemorrhage (VH) in proliferative sickle erozygous HbS and Haemoglobin electro- The patient was counselled and planned cell retinopathy (PSCR). phoresis AS. for surgery both eyes. He was planned for Fundus Fluorescein Angiogragraphy pars plan vitrectomy (PPV) plus mem- (FFA) was done with arm retina time of brane peeling (MP), endo-laser (EL) and 15 seconds. Fovea Avascular Zone (FAZ) fluid-air exchange (FAE). He had surgery appeared to be normal in both eyes. Ar- done on the RE from elsewhere. Unfor- eas of capillary non-perfusion (CNP) were tunately, he developed post-operative noted in both eyes with areas of leakage endophthalmitis. He received intravitreal only found in the LE. antibiotics at UTH Eye Hospital. Figure 1: Fundus photos of the right eye showing vitreous haemorrhage taken in 2014 Figure 2: Fundus photo right eye showing epiretinal membrane and tractional retinal detachment taken 2019 Figure 3: Fundus Fluorescein Angiography showing areas of leakage in the right eye 7 DISCUSSION This is what was noticed with the case CONCLUSION SCD is the most common and the most under review. Bothe eyes ended up being Though rare Proliferative Sickle Cell Ret- severe haemoglobinopathy [5]. Though blind. PSCR occurs rarely in patients with inopathy (PSCR) can occur in patients sickle cell disease is prevalent in black Af- sickle cell trait. Most cases occur if there with sickle cell trait. There is need to elic- ricans, routine sickling test is not done in is an associated systemic condition such it precipitating factors for patients with most Zambian hospitals. The result is that as diabetes, hypertension or sarcoidosis sickle cell trait that present with retinop- very few sickle cell trait carriers know of or if there is history of ocular trauma [1,6]. athy. Both Sickle cell disease patients and their genetic condition. In this case there was no pointer to any those with sickle cell trait need regular Sickle retinopathy can have devastating co-morbidity systemic condition. While ophthalmological examination. consequences and may lead to severe vi- other blood tests were normal, he was sual impairment and blindness if left un- positive for sickle cell trait which was con- treated. firmed by haemoglobin electrophoresis. LIST OF REFERENCES 1. Bowling, B., 2016. Kanski’s Clinical Ophthalmology, A Systematic Approach, Eighth. ed. Elsevier Limited, Sydney, Australia. 2. Bwalya, W.M. (2014) Ocular manifestations of sickle cell disease at the University Teaching Hospital, Lusaka, Zambia 3. de Melo, M.B., 2014. An eye on sickle cell retinopathy. Rev. Bras. Hematol. E Hemoter. 36, 319–321. https://doi.org/10.1016/j. bjhh.2014.07.020 4. Goldberg M.F. (1971) Classification and pathogenesis of proliferative sickle retinopathy. American Journal of Ophthalmology, 71 (3), pp. 649-665 5. Menaa, F., Khan, B.A., Uzair, B., Menaa, A., 2017. Sickle cell retinopathy: improving care with a multidisciplinary approach. J. Multidiscip. Healthc. 10, 335. https://doi.org/10.2147/JMDH.S90630 6. Jackson, H., Bentley, C.R., Hingorani, M., Atkinson, P., Aclimandos, W.A., Thompson, G.M., 1995. Sickle retinopathy in patients with sickle trait. Eye 9, 589–593. https://doi.org/10.1038/eye.1995.145 8.